Cemtrex ROCE
Was ist das ROCE von Cemtrex?
ROCE von Cemtrex Inc. ist -41.98%
Was ist die Definition von ROCE?
Die Kapitalerträge (ROCE) entsprechen einer Finanzkennzahl, die die Rentabilität eines Unternehmens und die Effizienz, mit der sein Kapital verwendet wird, misst.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE von Unternehmen in Industrials Sektor auf NASDAQ im Vergleich zu Cemtrex
Was macht Cemtrex?
cemtrex, inc. (nasdaq:cetx) is a diversified technology company that's driving innovation in a wide range of sectors, including smart technology, virtual and augmented realities, advanced electronic systems, industrial solutions, and intelligent security systems.
Unternehmen mit roce ähnlich Cemtrex
- Apogee Minerals Ltd hat ROCE von -42.19%
- Foresight Autonomous Ltd hat ROCE von -42.15%
- Conscience Capital hat ROCE von -42.15%
- Tonix Pharmaceuticals hat ROCE von -42.12%
- Xau Resources Inc hat ROCE von -42.12%
- Ameri Inc hat ROCE von -42.09%
- Cemtrex hat ROCE von -41.98%
- Arcutis Biotherapeutics Inc hat ROCE von -41.97%
- MediWound Ltd hat ROCE von -41.91%
- Solid Biosciences Inc hat ROCE von -41.85%
- Bionano Genomics hat ROCE von -41.85%
- Mereo BioPharma plc hat ROCE von -41.84%
- Fairfax Africa hat ROCE von -41.81%